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Assessing the Effects of Metabolism of
Environmental Agents on Cancer Tumor
Development by a Two-Stage Model of
Carcinogenesis
by W. Y. Tan* and Karan P. Singht
By combining the Michaelis-Menten kinetics of metabolism with the two-stage model of Moolgavkar
and Knudson (1981) and the extended two-stage model of carcinogenesis proposed by Tan and Gastardo
(1985), this paper proceeds to investigate the effects of metabolism of carcinogens on cancer tumor de-
velopment. It is shown that the nonlinear kinetics of metabolism ofcarcinogens affect the dose-response
relationship mainly through the mutation rates. If the initiator is affected by metabolism, then the
metabolism of promoters has very little or negligible effects of the expected incidences and the number
of tumors.
Introduction
Inassessingeffectsofenvironmentalagents on cancer
development, it is important to note that the biological
dose inside the cell is quite different from the exposure
dose, and it is the biological dose that is directly re-
sponsible for cancer development. For example, Hoel,
Kaplan, and Anderson (1) have shown that it is not the
exposed dose but the DNA adduct ofagents that gives
a linear dose-response curve for small doses. By using
Michaelis-Menten kinetics, Van Ryzin and Rai (2) and
Van Ryzin (3) have shown that for the Weibull model,
the one hit model, the multistage model, and the ap-
proximate multihit model, the nonlinear kinetics of me-
tabolism ofcarcinogens have significant impact ondose-
response relationships in risk assessment. Further, as
shown by Van Ryzin (4), in risk assessment, different
models give very different results.
To provide a mathematical description ofthe carcin-
ogenic processwhich canbeusedtointerprettheresults
of experimental animal and human epidemiologic stud-
ies, Moolgavkar and Venzon (5) and Moolgavkar and
Knudson (6) proposed a two-stage model ofcarcinogen-
esis. They modeled only two stages because no more
than two distinct stages have been experimentally dem-
onstrated. This model assumes that a malignant tumor
develops from a normal stem cell after two cellular
changes such as activation of cellular oncogenes; it dif-
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fers from the commonly used Armitage-Doll multistage
model (7,8) in that the two-stage model includes sto-
chastic birth and death processes to describe cell pro-
liferation and differentiation of both normal stem cells
and premalignant initiated cells (i.e., cells that have
undergone only the first cellular change). By assuming
different tissue growth patterns, Moolgavkar and
Knudson (6) showed their model could fit incidence
curves of all human cancers, while the Armitage-Doll
model could only fit most tumors ofadult onset. In add-
tion, Moolgavkar (9) and Tan and Gastardo (10) have
shown that the Moolgavkar-Venzon-Knudson (MVK)
two-stage modelprovides anexplanation forthe results
of initiation-promotion animal carcinogenesis experi-
ments, the initiator affecting the rate of occurrence of
the first cellular change and the promoter affecting the
proliferation rates ofthe initiated cells. The discovery
ofantioncogenes (11)provides biological supportforthe
MVK model. As noted by Moolgavkar (12), pedigree
analyses have shown that human cancers in some fam-
ilies are transmitted in an autosomal-dominant fashion.
Cytogenetic analyses ofthese hereditary cancers have
revealedthatparticulargenesaredeleted. Thus, incon-
trast to oncogenes, it is the inactivation of these an-
tioncogenes that leads to malignancy. Examples ofan-
tioncogenes include the retinoblastomas rb gene on
chromosome 13 (13-15) and the Wilm's tumorwm gene
on chromosome llp (16-18).
Since it is definitely desirable to use biologically sup-
ported models ofcareinogenesis to performrisk assess-
ments of carcinogens, in this paper, we proceed to as-
sess effects of metabolism of environmental agents byTAN AND SINGH
combining the Michaelis-Menten kinetics ofmetabolism
ofcarcinogens with the two-stage model ofMoolgavkar
and Knudson (6) and the extended two-stage model of
Tan and Gastardo (10).
Nonlinear Kinetics of Metabolism of
Carcinogens and Carcinogenesis
As a well-documented example, it has been observed
that mouse skin, when first treated by an initiator such
as 7,12-dimethylbenz[a]anthracene (DMBA) and then
followed by a promoter such as 12-O-tetradecanoyl-
phorbol-13-acetate (TPA), gives rise to papillomas that
may further progress with avery lowrate ofconversion
to yield squamous cell carcinomas (malignant conver-
sion) (19); however, Hennings et al. (20) reported that
initiators such as N-methyl-N'-nitro-N-nitroso-guani-
dine (MNNG) or 4-nitroquinoline-N-oxide (r-QO), but
not promoters, would induce carcinomas from papillo-
mas. These results suggest different effects of metab-
olism ofinitiators and promoters. In terms of the two-
stage model of Moolgavkar and Knudson (6), initiators
are associated withthe mutationrates, while promoters
are related to proliferation and differentiation rate of
initiated cells.
Effects of Metabolism of Carcinogens
That Are Initiators
To initiate carcinogenesis, carcinogens are first con-
verted metabolicallyinto chemically reactive forms that
bind covalently to DNA adducts, leading to DNA le-
sions. The DNA lesions may be repaired (normal), or
not repaired (die), or mismatched repaired, which leads
to mutations (21). Recent experimental results of mo-
lecular biology have confirmed this theory for initiation
of carcinogenesis. For example, Zarbl, Sukumar, and
Barbacid (22) reported that, by injecting nitrosomethy-
lurea (NMU) into the breast offemale rats, NMU binds
with DNA. Such a binding induces a G (guanine) to A
(adenine) base transition at codon 12 of the ras gene,
thusinitiatingthecarcinogenesis process (initiationpro-
cess).
To assess effects of metabolism of a carcinogen that
is an initiator, we let C, M, and DM denote the carcin-
ogen, the chemically activated metabolite of C and the
DNA adduct, respectively. As illustrated in Gehring
and Blau (23) and Hoel, Kaplan and Anderson (1), C
may either be excreted or activated electrophilically to
produce M; similarly, M is either detoxicated (deleted
fromthe cell) orcovalently bound to DNAtoyield DNA
adduct leading to DNA lesion. It is the mismatched
repaired DNAlesion(error-pronerepair)thatislinearly
related to the mutation rate al(I) of normal stem cells
induced by mutagens and carcinogens. Let [C], [M],
and [DM] denote, respectively, the concentrations ofC,
M, and DM and let q be the portion of mismatched
repaired DNA lesion. ([C] is normally the exposed
dose.) Then a1(j) a CDq[DM] so that aol() = C[DM] for
some constant C, where CD is the proportional constant
for DM DNA lesion. Let ao be the spontaneous mu-
tation rate ofnormal stemcells. As illustrated inTrosko
and Chang (21), spontaneous mutation is probably
caused by error-prone replication of normal DNA, in-
dependently ofinduction of mutation by mutagens and
carcinogens. It follows that one may express the mu-
tation rate ox1 ofnormal stem cells byoX1 = aoo + P[DM],
where ,B is a constant.
Torelate [DM] tothe exposed dose [C] ofthe initiator
C, we assume Michaelis-Menten kinetics for both the
activation process and the covalent binding process, but
first-order kinetics for detoxication and other eliminat-
ing processes. Assuming steady-state condition for the
metabolism, then, as shown in Van Ryzin (3),
[M] = ClVA[C]I(KA + [C])
and
[DM] = C2VB[M]/(KB + [M]), (1)
where (VA, KA) are the Michaelis-Menten constants for
the activation process; (VB, KB) are the Michaelis-Men-
ten constants for the covalent binding process; and C1
and C2 are functions of detoxication rates and rates of
other eliminating processes. This gives
[DM] = ClC2VAVB[C]I{KAKB + (KB
+ ClVA)[C]} = Y[C]I(1 + 8[C]),
where y = ClC2VAVBI(KAKB)
and 8 = KB + C1VA/(KAKB).
Effects of Metabolism of Carcinogens
That Are Promoters
The exact mechanism of how promoters increase cell
proliferation remains illusive. However, aroughpicture
painted by molecular biologists seems to suggest that
promoters facilitate the release ofactive oxygen species
(2, HO, 02*, and H202) or free radicals or organic
peroxides and their degradation products, which may
mediate the induction ofpoly (ADP)-ribosylation of nu-
clear proteins for cell proliferation and macromolecular
synthesis (24-27). Forthese electrophilic processes and/
or enzymatic processes, one may again assume Michae-
lis-Menten kinetics. Assuming first-order kinetics for
detoxication processes and other elimination processes,
the exposed dose [C] is then related to the biological
dose [B] by
[B] [C],
where -y and 8 are constants that are functions of Mi-
chaelis-Menton constants, detoxication rates, and rates
of other eliminating processes.
Let b1-dl be the difference between cell proliferation
rate and cell differentiation rate of initiated cells. The
above results then suggest that b1 = (b -d) + 1[B]
= (b -d) + 13y[C]/ (1 + b[C]), where is a constant,
(2)
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and b-d is the natural background difference of cell
proliferationrateandcelldifferentiationrateofinitiated
cells.
Assessing Effects of Metabolism of
Carcinogens by a Two-Stage Model
of Carcinogenesis
In this section we illustrate how to use the two-stage
model ofMoolgavkar and Knudson (6) and the extended
model ofTan and Gastardo (10) to assess effects ofme-
tabolism of carcinogens on cancer tumor development.
Specifically, we shall illustrate how the metabolism of
carcinogens affects the expected incidence rate and the
expected number of tumors by using the two-stage
models ofMoolgavkarand Knudson(6)andtheextended
two-stage model of Tan and Gastardo (10). Note that
the Tan-Gastardo extended model appears to provide a
realistic model for many human cancers, including, for
example, breast and ovary cancers (28). This is ex-
pected, since for breast and ovary cancers, hormone
(estrogen) levels are different over different time in-
tervals, so that menarche, menopause, and the time of
firstpregnancy provide naturalpartitions ofthelifetime
interval.
Assessing Effects of Metabolism by the
Two-Stage Model of Moolgavkar and
Knudson
Let the first and second mutation rates be ao1 and t2,
respectively, and let the birth rate and the death rate
forintermediate cells be b and d, respectively. Then for
small a2, the expected incidence function X(t) is given
approximately by
Toillustrate howthe nonlinearkinetics ofmetabolism
ofcarcinogens affect cancer tumor development, we as-
sume that a carcinogen with concentration c is applied
during [O,t] and that this carcinogen affects only the
first mutation rate (initiation process) so that a1 is now
replaced by al + ccxll, where e= yc/(l + bc) is the
biological dose (i.e., concentration ofDNA adduct) and
c is the exposed dose. If 8 = 0 and/or the metabolism
is not acting, thenboth A(t) and ,u(t) forfixed t are linear
functions of c; on the other hand, ifthe Michaelis-Men-
ten nonlinear kinetic is acting so that y 4 0 and 8 + 0,
then X(t) and ,u(t) for fixed t are nonlinear functions of
c. If the carcinogen affects also a2 and/or birth and
death, then by replacing a2 and b-d by at2 + ea22 and
(b-d) + ce, respectively, one may readily assess the
effects of nonlinear kinetics of carcinogens on X(t) and
R(t).
Assessing Effects by the Extended Two-
Stage Model of Carcinogenesis
Let the time interval [0, t] be partitioned by Ij =
[ti1, t0), j= 1,. . . k- 1 and Ik = [tk-l, tk] with to = 0 and
tk = t. For the jth interval, Ij, assume that the first
and second mutation rates are aolj and a2j, respectively,
and that the birth rate and the death rate for the in-
termediate cells are given, respectively, by bj and dj.
Then, for smalla2j, theexpected incidence X(tk) at t =tk
is given approximately by:
k
O -t2kE tli[ti(O
i=l
{ k
expt I 0b - d.7
j=i+1 (6)
A(t) a1a2f X(s)exp[(b - d)(t - s)]ds
where X(s) is the expected number of normal cells
time s given a large number of normal cells at s =
[For proof, see (6)].
The expected number ,u(t) and the variance V(t)
tumors at time t are given, respectively, by:
,u(t) = aif X(t - s)Vtj(s)ds
and
V(t) = aif X(t - s),u2(s)ds
where
Al(t) = a2[exp(Et) - l]/E
and
pu2(t) = exp[E(t -S)]{2
+ 2a2ill(s) + 2bR'(s)}ds,
with E = b - d - at2
(3)
at
A
where (i = ti - ti- 1,
j( j) = fX(s)exp[(bj - - a2j)(tj - s)]ds
V. with Xj(s) being the expected number of normal cells
k
of at tj-l +s, and E is defined as 0. [For proof, see Tan
j=k+l1
and Gastardo (10)].
(4) Assume that each cell after the second mutation de-
velops instantaneously into a cancer tumor. Then, by
using the probability generating functions, one may
readily obtain the expected number ,(t) and variance
(5) V(t) of tumors at time t=tk-
As shown in the Appendix, we have:
k
11(t) = >aijJ Xj(s)*ilj((j - s)ds,
Rlj(t)
= f1i(t)Wj+I + f2j(t);
k V
V(t) = aLj X(s)ji2j(tj - s)ds + R1(t), j= 1J
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Table 1. Parameter values for generating data by computer.
No = 106, M = 2 x 106, c = 0, 10, 25, 50, 100.
Case 1
(1.1) (bm,dN) = (0.04,0.004), (b = bN, d = 0); a, = 10' + c i0'
c = lyc/(l + 8c), (y, 8) = (1,0), (0.2, 0.6), (0.2, 0.01), (1.4,
4.2), (1.4, 0.07), a2 = 10-.
(1.2) All parameters are the same as those of (1.1) except (bN,
dN) = (0.025, 0.002).
Case 2
(2.1) For the first interval, all parameters are the same as those
of (1.1) of case 1 (initiation). For the second interval, all
parameters are the same as those ofthe first interval
except a, = a2 = 10' (no initiation for second interval).
(2.2) All parameters are the same as those of (2.1) except (bN,
dN)= (0.025, 0.002).
(2.3) For the first interval, all parameters are the same as those
of (2.1) (initiation). For the second interval, all parameters
are the same as those of (2.1) except
b2= bN + Pt, C = Wyc/( + Sc),
, = 0.001 to correspond to experiments of Stenbeck et
al. (37) (promotion for second interval).
(2.4) All parameters are the same as those of (2.3) except
(bN= 0.025, dN = 0.002).
jL2j(t) = h1j(t) W_2+1 + h2j(t)Wj+1 + h3j(t) +fij(t) Ujj+1,
wherefgi(t), i = 1, 2; huj(t), u= 1, 2, 3, Wj and U1, j=
1,..., k, are given in the Appendix.
Let c be the exposed dose of carcinogen over the Ij
intervaf. Replacing ait by ao +cja0j, where Cj = -ycj!
(1 +bcj), if au in the Ij interval is affected by the car-
cinogen and replacing bj -dj by (bj -dj) +ej, if the
birth rate and death rate in Ij is affected by the carcin-
ogen, one may evaluate the effects ofnonlinear kinetics
of metabolism of carcinogens on X(tk) and tOk) at tk.
Some Numerical Results
To illustrate the effects of metabolism of environ-
mental agents on cancer tumor development, we gen-
erated some data by computer. Two cases are consid-
ered: In case 1, the time consists of one time interval
oflength 55 units; in case 2, the time is divided into two
time intervals with length 15 and 40 units. Thus, case
1 is related to the Moolgavkar-Knudson two-stage
model, while case2is related tothe extended two-stage
model ofTan and Gastardo (10). In generating data, wue
followMoolgavkarandVenzon(5)andTanandGastardo
(10) to assume logistic growth for normal cells with
= 2 x 106 (maximum population size) and with No
106 as the initial number ofnormal cells. We chose the
birth rate bN and death rate dN ofnonnal stem cells as
(bN, dN) = 0.04, 0.004) and (bN, dN) = (0.025, 0.002)
to correspond, respectively, to doubling time 18 days
of microbial cell populations (29,30) and doubling time
28 days of human tissue cells (31). For the birth rate
and death rate ofintermediate cells, because ofthe re-
ports by Mackillop et al. (32), Buick and Pollak (33),
and Oberley and Oberley (34) that normal stem cells
become immortalized by the loss of differentiation ca-
pability (35,36), we chose (b, d) = (bN, 0). Since spon-
taneous mutation rates are normally between i07 and
, we chose the spontaneous rate to be 10-; further,
concentrations arechosen as 0, 10, 25, 50, and 100units.
For the (y, 5) values, we chose (-y, 5) = (1, 0) to cor-
respond to the situation of no metabolism and chose (y,
8) = (0.2, 0.6), (0.2, 0.01) and (y, 8) = (1.4, 4.2), (1.4,
0.07). Note that = 0.2 is the value used by Van Ryzin
Table 2. Expected incidence and expected number of tumors (scale: per million).a
Incidence Expectation
Concentration a c d e a b c d e
Case 1. Experiment (1.1)
0 2.6101 0.0164 0.0164 0.0164 0.0164 65.0287 0.1857 0.1857 0.1857 0.1857
10 16.4073 0.4847 2.9966 0.5500 13.5148 185.8719 5.4910 33.9468 6.2313 153.1037
25 40.9937 0.5286 6.5727 0.5576 20.8776 464.4012 5.9884 74.4602 6.3168 236.5136
50 81.9710 0.5451 10.9437 0.5602 25.5134 928.6166 6.1756 123.9765 6.3459 289.0309
100 163.9256 0.5538 16.4037 0.5615 28.7005 1857.0475 6.2738 185.8719 6.3605 325.1365
Case 1. Experiment (1.2)
0 2.4158 0.0155 0.0155 0.0155 0.0155 60.1930 0.1855 0.1855 0.1855 0.1855
10 15.4926 0.4577 2.8295 0.5194 12.7613 185.6713 5.4851 33.9102 6.2246 152.9385
25 38.7082 0.4991 6.2063 0.5265 19.7136 463.9000 5.9819 74.3798 6.3100 236.2583
50 77.4008 0.5147 10.3335 0.5289 24.0909 927.6145 6.1689 123.8427 6.3390 288.7189
100 154.7862 0.5229 15.4926 0.5302 27.1004 1855.0434 6.2670 185.6713 6.3537 324.7856
Case 2. Experiment (2.1)
0 1.1599 0.0202 0.0202 0.0202 0.0202 0.2066 0.2066 0.2066 0.2066 0.2066
10 10.1124 0.3085 1.8551 0.3487 8.3314 206.8068 6.1095 37.7703 6.9331 170.3480
25 25.2509 0.3355 4.0571 0.3534 12.8649 516.7071 6.6629 82.8467 7.0283 263.1523
50 50.4816 0.3457 6.7483 0.3550 15.7193 1033.2077 6.8711 137.9401 7.0606 321.5847
100 100.9430 0.3511 10.1124 0.3558 17.6817 2066.2087 6.9804 206.8068 7.0769 361.7570
Case 2. Experiment (2.2)
0 0.5467 0.0123 0.0123 0.0123 0.0123 0.1303 0.1303 0.1303 0.1303 0.1303
10 4.9803 0.1543 0.9161 0.1741 4.1058 130.4513 3.8538 23.8250 4.3733 107.4535
15 12.4391 0.1676 2.0006 0.1764 6.3387 325.9327 4.2029 52.2587 4.4334 165.9933
50 24.8658 0.1727 3.3261 0.1772 7.7445 651.7351 4.3342 87.0110 4.4538 202.8518
100 49.7193 0.1753 4.9830 0.1776 8.7110 1303.3398 4.4031 130.4513 4.4640 228.1920
aa,b,c,d,e correspond to (y,8) = (1,0), (0.2, 0.6), (0.2, 0.01), (1.4, 4.2) and (1.4, 0.07), respectively.
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Table 3. Expected incidence and expected number of tumors for initiation-promotion experiments of case 2 (scale: per million).
Incidence Expectation
C, CP a b c d e a b c d e
Experiment 2.3
(i) Promotion (y,8) = (1,0)
0 25.2509 0.3355
10 37.6670 0.4977
25 25 68.6289 0.9020
50 186.5425 2.4417
100 1378.3346 18.0042
0 100.9430 0.3511
10 150.5864 0.5268
100 25 274.3814 0.9441
50 745.8358 2.5563
100 5510.9840 18.8510
(ii) Promotion (-y,&) = (1.4,4.2)
0 25.2509 0.3355
10 25.5818 0.3399
25 25 25.5865 0.3399
50 25.5881 0.3399
100 25.5889 0.3400
0 100.9430 0.3511
100 10 102.2661 0.3556
25 102.2850 0.3556
50 102.2914 0.3557
100 102.2946 0.3557
(iii) Promotion (y,8) = (1.4,0.07)
0 25.2509 0.3355
25 10 35.1002 0.4642
25 42.0079 0.5544
50 74.0389 0.6201
100 50.8430 0.6697
0 100.9430 0.3511
100 10 140.3236 0.4857
25 167.9428 0.5802
50 188.0581 0.6490
100 203.2681 0.7010
(i) Promotion (-y,&) = (1,0)
0 12.4391 0.1676
25 10 18.5543 0.2475
25 33.8039 0.4468
50 91.8795 1.2054
100 678.8697 8.8735
0 49.7193 0.1753
100 10 74.1699 0.2589
25 135.1421 0.4675
50 367.3453 1.2619
100 2714.3013 9.2906
(ii) Promotion (-y,&) = (1.4,4.2)
0 12.4391 0.1676
25 10 12.6020 0.1698
25 12.6044 0.1698
50 12.6052 0.1698
100 12.6055 0.1698
0 49.7193 0.1753
100 10 50.3710 0.1775
25 50.3802 0.1775
50 50.3810 0.1776
100 50.3850 0.1776
(iii) Promotion (-y,8) = (1.4,0.07)
0 12.4391 0.1676
25 10 17.2901 0.2310
25 20.6924 0.2755
50 23.1702 0.3078
100 25.0439 0.3323
0 49.7193 0.1753
100 10 60.1152 0.2416
25 82.7184 0.2882
50 92.6257 0.3221
100 100.1171 0.3477
4.0571
6.0495
11.0182
29.9403
221.1928
10.1124
15.0831
27.4784
74.6838
551.8048
4.0571
4.1102
4.1109
4.1112
4.1113
10.1124
10.2449
10.2468
10.2474
10.2478
4.0571
5.6376
6.7462
7.5535
8.1640
10.1124
14.0555
16.8210
18.8350
20.3580
2.0006
2.9820
5.4292
14.7492
108.9489
4.9830
7.4312
13.5363
36.7864
271.7834
2.0006
2.0267
2.0271
2.0272
2.0273
4.9830
5.0483
5.0492
5.0495
5.0497
2.0006
2.7791
3.3251
3.7227
4.0234
4.9830
6.9251
8.2872
9.2792
10.0293
0.3534
0.5243
0.5905
2.5736
18.9789
0.3557
0.5279
0.9570
2.5912
19.1085
0.3534
0.3579
0.3580
0.3580
0.3581
0.3558
0.3603
0.3604
0.3604
0.3605
0.3534
9.3724
56.4879
175.0843
381.0867
0.3558
9.4364
56.8739
176.2807
383.6907
0.1764
0.2607
0.4707
1.2704
9.3536
0.1776
0.2624
0.4738
1.2790
9.4174
0.1764
0.1787
0.1787
0.1787
0.1787
0.1776
0.1799
0.1799
0.1799
0.1799
0.1764
0.2432
0.2901
0.3242
0.3500
0.1776
0.2449
0.2920
0.3264
0.3524
12.8649 516.7071
19.1893 664.2643
34.9603 990.2506
95.0217 2028.7507
702.0829 9820.2650
17.6817 2066.2087
26.3750 2656.2602
48.0536 3959.8146
130.6131 8112.5693
965.0697 39269.2810
12.8649 516.7071
13.0334 520.8467
13.0358 520.9048
13.0367 520.9248
13.0371 520.9348
17.6817 2066.2087
17.9133 2083.7588
17.8167 2083.9942
17.9178 2083.0741
17.9183 2083.1143
12.8649 516.7071
17.8818 634.8830
21.4004 712.8976
23.9630 767.8132
25.9007 808.4392
17.6817 2066.2087
24.5779 2538.7705
29.4144 2850.7351
32.9370 3070.3318
35.6005 3432.7869
6.3387 325.9327
9.4536 410.8152
17.2213 595.9896
46.8034 1175.4025
345.7991 5405.0006
8.7110 1303.3398
12.9928 1642.7579
23.6701 2383.2435
64.3330 4700.2000
475.3266 21612.5190
6.3387 325.9327
6.4217 328.3263
6.4229 328.3603
6.4233 328.3719
6.4236 328.3777
8.7110 1303.3398
8.8251 1312.9112
8.8268 1313.0474
8.8273 1313.0936
8.8276 1313.1168
6.3387 325.9327
8.8096 393.9810
10.5427 438.6174
11.8048 469.9259
12.7592 493.0349
8.7110 1303.3398
12.1076 1575.4513
14.4898 1753.9435
16.2247 1879.1399
17.5366 1971.5482
6.6629 82.8467 7.0283 263.1523
8.5656 106.5054 9.0354 338.3013
12.7691 158.7727 13.4695 504.3220
26.1604 325.2815 27.5953 1033.2168
126.6308 1574.5407 133.5763 5001.3352
6.9804 206.8068 7.0769 361.7570
8.9738 265.8659 9.0979 465.0647
113.3776 396.3378 13.5627 693.2942
127.4071 811.9870 27.7861 1420.2689
132.6654 3930.4619 134.5002 6875.3636
6.6629 82.8467 7.0283 263.1523
6.7162 83.5102 7.0846 265.2602
6.7170 83.5197 7.0854 265.2902
6.7172 83.5229 7.0857 265.3003
6.7174 83.5245 7.0858 265.3054
6.9804 206.8068 7.0759 361.7570
7.0363 208.4633 7.0336 364.6546
7.0371 208.4869 7.1344 364.6958
7.0374 208.4949 7.1347 364.7098
7.0375 208.4989 7.1348 364.7169
6.6629 82.8467 7.0283 263.1523
8.1867 101.7945 75.2446 323.3378
9.1927 114.3031 333.3727 363.0696
9.9008 123.1080 884.3603 391.0374
10.4247 129.6218 1751.0411 411.7277
6.9804 206.8068 7.0769 361.7570
8.5769 254.1055 75.7650 444.4943
9.6308 285.3301 335.6784 499.1138
10.3727 307.3095 890.4769 537.5614
10.9215 323.5696 1763.1521 566.0044
4.2029 52.2587
5.2973 65.8684
7.6852 95.5585
15.1566 188.4592
69.6966 866.6155
4.4031 130.4513
5.5498 164.4246
8.0514 238.5288
15.8789 470.4430
73.0180 2163.2969
4.2029 52.2587
4.2337 52.6425
4.3242 52.6479
4.3243 52.6498
4.2344 52.6507
4.4031 130.4513
4.4355 131.4093
4.4359 131.4229
4.4361 131.4275
4.4362 131.4299
4.2029 52.2587
5.0803 63.1693
5.6559 70.3261
6.0596 75.3460
6.3576 79.0512
4.4031 130.4513
5.3224 157.6869
5.9254 175.5522
6.3484 188.0831
6.6606 197.3323
4.4333 165.9933
5.5880 209.2229
8.1067 303.5299
15.9880 598.6174
73.5194 2752.6976
4.4640 228.1920
5.6266 287.6199
8.1628 417.2642
16.0985 822.9227
74.0279 3784.1488
4.4333 165.9933
4.4659 167.2124
4.4663 167.2297
4.4666 167.2356
4.4666 177.2386
4.4640 228.1920
4.4968 229.8678
4.4972 229.8916
4.4974 229.8997
4.4975 229.9038
4.4333 165.9933
5.3590 200.6495
5.9661 223.3822
6.3920 239.3273
6.7063 251.1096
4.4640 228.1920
5.3960 275.8339
6.0074 307.0848
6.4362 329.0045
6.7527 345.1836TAN AND SINGH
and Rai (2). For each value of-y, two 8 values are chosen
to correspond to the situations y/y = 1/3 < 1 and y/8
= 20 > 1 [note the values used by Van Ryzin and Rai
(2) are -y = 0.2 and 8 = 0.00048]. To clarify different
experimental situations, we give in Table 1 parameter
values for the above two cases. Note that for case 2,
we considered only the situations of initation and ini-
tiation followed by promotion; we did not present sit-
uations of promotion only because effects of promotion
are negligible ifinitiatoris not applied before promotion
(9,10,37). To determine effects of choice of different
parameter values, we have done computations formany
other sets of parameters than those given in Table 1
(38). Since the results are quite similar, we present only
numerical results for parameters given in Table 1.
Using parameter values ofTable 1, we computed the
expected incidences and the expected numbers of tu-
mors; some of the results are given in Tables 2 and 3
to illustrate some basic characteristics ofthe model and
its consequences. From these results the following ob-
servations are made:
For initiators, if metabolism is not acting, then both
the incidences and the expected numbers oftumors are
linearly related to exposed dose of initiators. This is
predicted from formulas given previously. If metabo-
lism is functioning and ifthe carcinogen is an initiator,
then the dose-response curves are no longer linear; for
cases where y/8 < 1, although the incidences and the
expected number of tumors for c > 0 are considerably
greater than those for c = 0 (no initiator), little changes
in incidences and expected tumors are observed for dif-
ferent c > 0 values. On the other hand, if y18 > 1, then
both the incidences and expected number oftumors in-
crease monotonically as c increases.
For initiation and promotion experiments, if the ini-
tiator is not affected by metabolism, then both the in-
cidences and the expected numbers of tumors are af-
fected by promoters; furthermore, metabolism of
promoters would reduce significantly the cancer inci-
dence rates and the expected number oftumors. On the
other hand, if initiator is affected by metabolism, then
the metabolism of promoters have little effect. This is
expected since metabolism of initiators would signifi-
cantly reduce the number of initiated cells while the
function ofpromoters is to facilitate cellproliferation of
intiated cells.
APPENDIX 1: DERIVATION OF i(t)
AND V(t) FOR THE EXTENDED
TWO-STAGE MODEL OF TAN AND
GASTARDO
Let 4(tk) = ](u,v,tk) be the PGF (probability gen-
erating functon) of intermediate cells and tumors at t
= tk given a large number ofnormal cells at t = 0, and
let 4j(Q) = 4j(u,v,Q) be the PGF ofintermediate cells
and tumors at t = tj given one intermediate cell at t =
ti - . Then, if each cell after the second mutation de-
velops into a single tumor instantaneously, it is shown
in Tan and Gastardo (10) that
k =i
O(k) = exp{ altj )(j(s)[gj(tj
- s) - l]ds}, (a.1)
where xy(s) is the expected number of normal cells at
tj- 1 + s given a large number ofnormal cells at time t
= 0, gk(X) = k(U,V,x) andgj(x) = [gjq+1(j+ 1),(v,x], i
=2 12...,9k - 1.
By taking derivative with respect to v over I(tk) and
putting u = v = 1, one has:
k rtl
pW(tk) = Ealjl Xj(s)>tj(tj- s)ds,
where
ALlj(t) = [ug>( )]-u=v=
Puttingforj = 1,2,..., k - 1,
f1j(t) = [-A4i(u 1,t)] = exp(E3t),
[a 1 f21(t) = -4j(l,v't)
and
(a.2)
= a2j[exp(Ejt) -l/E
Wj = Pulj(tj), where Ej = bj - dj, then
1i(t) = fl1(t)W1+1 +f2j(t)
and
W =_AjW+1 + BJ,
where
Ai = fij(t,) = exp((E1 ) and
Bj = f2j(Q) = a2j[exp(Ejj) - l]/Ej.
From (a.3) it follows that forj = 1,..., k,
k (u-1
W. = EBu flAv , Wk+l = 0
and
1i'(t) = flj(t)Wj+1 + f2j(t)
k u-{ +
= fij(t) E Bu~f AVi + f2j(t),
u=j+l lv=j+lJ
(a.3)
(a.4)
0 k
forj = 1,...,k, where Hl is defined as 1 and E is
1 u=k+1
defined as 0.
Bytakingthesecondderivative withrespecttovover
W(tk) and putting u = v = 1, one has:
k > f
112(t) = aljo V^s)R2j(s)ds + ,ul(t), (a.5)
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where
[~~t
a2 ]
Put, forj = 1, 2,... k:
hij(t) = (2bj/Ej)exp(Ejt)[exp(Ejt) - 1],
h21(t)= (2a2jIEj2)exp(Ejt)[-Ej(bj
+ dj)t - 2b1 + 2bjexp(ejt)], (a.6)
h37(t) = (Ot2j/E3){Eiexp(Ejt) - Ej- 2Ei(bj + di)t exp(Eit)
+ 2[dj + bj]/[exp(Ejt) -1]}
Hj = h j(Q, Gj = h2j(Qj) and Fj = h3j(Q.
Then, with
Uj = f21(Qi)
U, = HW1+1 + GW+l + AjU + Fj, (a.7)
j = 1,.. .,k, Uk+l = 0;
Pi2j(t) = hlj(t)WVV+1 +h2j(t)WjV+ + h3j(t)
+AAjt)Uj+1(a.8)
j=1,...,k.
From (a.7), one has
k-l u-l
U1 = (HuWu2+1 + GuWu+1 + Fu)HjAV
U=j V=i
+ Fk(HAV)
j = 1,... ,k, Uk+1 =
k-l k-i
0, where > is defined as 0 and H defined as 1.
u=k v=k
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